Biotech | October 22, 2021
Rakuten Medical partners with Karkinos Healthcare to expand novel cancer care in India
This strategic collaboration will enable continued innovation in cancer care
This strategic collaboration will enable continued innovation in cancer care
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
Lifebit's accompanying suite of AI-powered end-to-end software solutions provide faster data insights, accelerate drug discovery pipelines, and improve clinical trials success
It is a recombinant nanoparticle protein-based vaccine
Takeda is establishing the capability to manufacture TAK-019 (known outside Japan as NVX-CoV2373) at its facilities in Japan and aims to begin distribution in the early calendar year 2022
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
The manufacture of finished doses will commence in 2022 and at full operational capacity, the annual production is expected to exceed 100 million doses annually
Subscribe To Our Newsletter & Stay Updated
